Results 81 to 90 of about 14,471,607 (152)

Comparative analysis of the predictive value of the ASAP model and the GAAD model for liver cancer high risk cohorts. [PDF]

Sci Rep
Zhang L, Xie C, Huang Y, Jiang D.
europepmc   +1 more source

Clinical effectiveness of tumor marker des-gamma-carboxyprothrombin in Chinese patients with hepatocellular carcinoma

Clinical effectiveness of tumor marker des-gamma-carboxyprothrombin in Chinese patients with hepatocellular carcinoma
学位の種別: 課程博士 審査委員会委員 : (主査)東京大学教授 瀬戸 泰之, 東京大学講師 須並 英二, 東京大学講師 阪本 良弘, 東京大学教授 小池 和彦, 東京大学准教授 四柳 ...
openaire   +1 more source

ABO-incompatibility and hepatocellular carcinoma recurrence after living donor liver transplantation: stratified by tumor burden. [PDF]

Transpl Int
Kang WH, Hwang S, Moon DB, Kim KH, Ahn CS, Ha TY, Song GW, Jung DH, Park GC, Yoon YI, Na BG, Kim SH, Kim SM, Lee SG.   +13 more
europepmc   +1 more source

Diagnostic performance of alpha-fetoprotein, lens culinaris agglutinin-reactive alpha-fetoprotein, des-gamma carboxyprothrombin, and glypican-3 for the detection of hepatocellular carcinoma: a systematic review and meta-analysis protocol. [PDF]

Syst Rev, 2013
Huang TS, Shyu YC, Turner R, Chen HY, Chen PJ.   +4 more
europepmc   +1 more source

JURNAL GAMMA, Volume 7, Nomor 2, Maret 2012

, 2014
JURNAL GAMMA, ISSN: 2086-3071 Volume 7, Nomor 2, Maret 2012 : Analisa Vegetasi Hutan Mangrove Pelabuhan Lembar Kabupaten Lombok Barat Nusa Tenggara Barat Amir Syarifuddin1 & Zulharman2.
Isi, Daftar
core  

Comparative performance of the GAAD and ASAP scores in predicting early-stage hepatocellular carcinoma. [PDF]

Gastroenterol Rep (Oxf)
Maneenil C, Sripongpun P, Chamroonkul N, Tantisaranon P, Jarumanokul R, Samaeng M, Yamsuwan Y, Fonghoi L, Numit A, Piratvisuth T, Kaewdech A.   +10 more
europepmc   +1 more source

GALAD, or des-gamma-carboxy prothrombin compared with alpha-foetoprotein for the diagnosis of hepatocellular carcinoma in people with chronic liver disease. [PDF]

Cochrane Database Syst Rev
Aralica M, Nadarevic T, Colli A, Casazza G, Vranić L, Fraquelli M, Poropat G, Štimac D.   +7 more
europepmc   +1 more source

Scientific, regulatory, and practical considerations for bringing hepatocellular carcinoma biomarkers into clinical practice. [PDF]

JHEP Rep
Botía Martínez-Artero B, Alimenti E, Carter JK, Pinato DJ, Villanueva A.   +4 more
europepmc   +1 more source

Spontaneous regression of hepatocellular carcinoma after alcohol and smoking abstinence and bone fracture surgery: A case report. [PDF]

Medicine (Baltimore)
Uchino K, Matsuzaki A, Yamamoto S, Taniguchi H, Yoshida H.   +4 more
europepmc   +1 more source

Two cases of unresectable hepatocellular carcinoma treated via atezolizumab and bevacizumab combination therapy. [PDF]

Surg Case Rep, 2023
Tsunemitsu R, Tabuchi M, Sakamoto S, Ogi K, Matsumoto M, Iwata J, Okabayashi T.   +6 more
europepmc   +1 more source